IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Trident Texofab IPO is a Fixed Price IPO listing on BSE SME exchange, with an ipo size of ₹ 3.53 Cr. The company is based in Surat and caters to Textiles sector. Guiness Corporate Advisors is the merchant banker of Trident Texofab IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 11th September 2017.
Trident Texofab IPO open date is 21st September 2017 and close date is 26th September 2017. IPO Allotment Date is 30th November -0001 and Listing date is 5th October 2017.
IPO
Size:
₹ 3.53 Cr.
Avg IPO Size (Sector Based)
: ₹
15.87 cr.
Sector: Textiles
SME
IPO so far:
91
Merchant Banker:
Guiness Corporate
SME
IPO by BRLM so far:
47
City:
Surat
SME
IPO so far:
40
Revenue (annualised):
₹
76.19
cr. 
PE
Ratio:
35.00x
Average Sector PE Ratio: 19.27x
Trident Texofab IPO size is ₹ 3.53 Cr. with IPO price of ₹ 30.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Guiness Corporate Advisors Private Limited is the book-running lead manager of the Trident Texofab IPO. Kfin Technologies Limited is the Registrar and Market Maker is Guiness Securities Limited for Trident Texofab IPO.
Trident Texofab IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Trident Texofab IPO, based in Surat, operates in the Textiles sector with a focus on Company and its range includes home furnishing bed sheets scarf pareos suiting and shirting and technical textile fabrics. The company is launching its SME IPO on the BSE SME exchange, using the Fixed Price Issue method. Trident Texofab IPO size is ₹ 3.53 Cr. with fresh issue size of ₹ 4 and Offer for sale being ₹ Nil
The IPO allotment date for Trident Texofab IPO is expected to be 30th November -0001, after the finalization of basis of allotment. Investors can check Trident Texofab IPO allotment status on the registrars website, Kfin Technologies Limited . Trident Texofab IPO refund dates are 30th November -0001.
Trident Texofab IPO is expected to be listed on 5th October 2017.
The upper price band for the Trident Texofab IPO is set at ₹ 30.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Trident Texofab IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Trident Texofab IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 26th September 2017. After submission, funds are blocked until the basis of allotment of Trident Texofab IPO is finalised.
The merchant banker for Trident Texofab IPO is Guiness Corporate Advisors Private Limited . Guiness Corporate Advisors Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Trident Texofab IPO RHP for further details.
The registrar for Trident Texofab IPO is Kfin Technologies Limited . Investors can go to Kfin Technologies Limited registrar website for IPO allotment status, refund processing, and other queries related to Trident Texofab IPO through their official website or helpline.
Trident Texofab IPO was subscribed 0.00 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 3.53 Cr.
Avg IPO Size (Sector Based)
:
₹ 15.87 Cr.
Sector: Textiles
SME
IPO so far:
91
Merchant Banker:
Guiness Corporate
SME
IPO by BRLM so far:
47
City:
Surat
SME
IPO so far:
40
Revenue (annualised):
₹ 75.95 cr.
PE
Ratio:
35.00x
Average Sector PE Ratio: 19.27x
Trident Texofab IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Trident Texofab Financial Review Page
Merchant Banker(s) of Trident Texofab IPO: Guiness Corporate Advisors Private Limited
Trident Texofab IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Trident Texofab IPO listed at a listing price of 68.00 against the offer price of 30.00.
The current market price of Trident Texofab is 214.85.
Why Us?
